Moderna and Aldevron Expand Collaboration
The focus will be on Moderna’s COVID-19 vaccine and additional programs in its clinical development pipeline.
Stay updated with breaking news from Breakthrough Campus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The focus will be on Moderna’s COVID-19 vaccine and additional programs in its clinical development pipeline.
Samsung Biologics to provide fill-finish manufacturing for Moderna’s COVID-19 vaccine Samsung Biologics will provide large-scale fill-finish manufacturing for Moderna’s COVID-19 vaccine from its facilities in South Korea. Upon execution of the deal, technology transfer will commence immediately. Samsung Biologics’ Incheon facilities will use a state-of-the-art production line equipped for aseptic fill-finish, labeling, and packaging services. The agreement will support the production of hundreds of millions of doses of Moderna’s COVID-19 vaccine, destined t...